Dare Bioscience (DARE) Return on Assets [ROA] (2017 - 2026)
Dare Bioscience (DARE) posted Return on Assets [ROA] of -43.54% for Q2 2026, up 73.28 percentage points from -116.82% a year earlier.
Powered by 
Analysis
Dare Bioscience (DARE) Return on Assets [ROA] (2017 - 2026) Analysis & Trends
For FY2025, Dare Bioscience's Return on Assets [ROA] came in at -49.66%, up 58.45 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a five-year change of +315.86 percentage points (FY2020 to FY2025).
- In prior years, Dare Bioscience's Return on Assets [ROA] was -108.11% in FY2024 (-13.07 pp), -95.04% in FY2023 (-32.04 pp), -63.00% in FY2022 (+60.32 pp) and -123.33% in FY2021 (+242.20 pp).
- Quarterly Return on Assets [ROA] has run from a low of -174.04% in Q3 2023 to a high of -42.80% in Q4 2025 over five years.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2021, with a gain of 285.57 percentage points; the weakest was Q3 2023, with a drop of 125.50 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Dare Bioscience | 12.89 Mn | -52.57 Mn | -132,343.00 | -43.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.54% |
| Dec 31, 2025 | -42.80% |
| Sep 30, 2025 | -79.80% |
| Jun 30, 2025 | -116.82% |
| Mar 31, 2025 | -107.99% |
| Dec 31, 2024 | -117.39% |
| Sep 30, 2024 | -112.11% |
| Jun 30, 2024 | -147.85% |
| Mar 31, 2024 | -167.38% |
| Dec 31, 2023 | -133.55% |
| Sep 30, 2023 | -174.04% |
| Jun 30, 2023 | -152.09% |
| Mar 31, 2023 | -84.56% |
| Dec 31, 2022 | -66.63% |
| Sep 30, 2022 | -48.54% |
| Jun 30, 2022 | -60.11% |
| Mar 31, 2022 | -75.77% |
| Dec 31, 2021 | -74.69% |
| Sep 30, 2021 | -119.33% |
| Jun 30, 2021 | -259.49% |
API Access
Dare Bioscience Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();